NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cancer Prevention Pharmaceuticals, Inc. to Panbela Therapeutics, Inc. (“the Company”) (NasdaqCM: PBLA). Under the terms of the proposed transaction, holders of Panbela common stock are expected […]
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Tenneco Inc. (NYSE: TEN) to affiliates of Apollo Global Management, Inc. (NYSE: APO). Under the terms of the proposed transaction, shareholders of Tenneco will receive only […]
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of TEGNA Inc. (NYSE: TGNA) to an affiliate of Standard General L.P. Under the terms of the proposed transaction, shareholders of TEGNA will receive only $24.00 in […]
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of BT Holdings, Inc. to Origin Bancorp, Inc. (NasdaqGS: OBNK) (“the Company”). Under the terms of the proposed transaction, BTH shareholders will receive an aggregate of 6,828,390 […]
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of South Jersey Industries, Inc. (NYSE: SJI) (“SJI”) to Infrastructure Investments Fund. Under the terms of the proposed transaction, shareholders of SJI will receive only $36.00 in […]
NEW YORK--(BUSINESS WIRE)--#Class--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cortexyme, Inc. (“Cortexyme” or the “Company”) (NASDAQ: CRTX) on behalf of Cortexyme stockholders. Our investigation concerns whether Cortexyme has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in […]
NEW YORK--(BUSINESS WIRE)--#Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Informatica Inc. (“Informatica” or the “Company”) (NYSE: INFA) on behalf of Informatica stockholders. Our investigation concerns whether Informatica has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in […]
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Vertiv Holdings Co (“Vertiv” or the “Company”) (NYSE: VRT) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Vertiv investments […]
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of C3.ai, Inc. (“C3.ai” or the “Company”) (NYSE: AI) investors concerning the Company’s possible violations of federal securities laws. On February 16, 2022, Spruce Point Capital Management published a report alleging that C3.ai has exhibited a “pattern of exaggerated business claims,” concluding […]
NEW YORK--(BUSINESS WIRE)--#C3--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against C3.ai, Inc. (“C3” or the “Company”) (NYSE: AI) on behalf of C3 stockholders. Our investigation concerns whether C3 has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in […]
Lawyer Monthly is a news website and monthly legal publication with content that is entirely defined by the significant legal news from around the world.
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you consent to the use of cookies. Privacy PolicyOkI do not consent